COVID-19: Delayed vaccine rollout estimated to cost $16.4 billion, new modelling shows
The current rate of vaccination is likely to set back the opening of Australia’s borders to the world by an extra 81 days, the report says, which will cost approximately $16.4 billion.
Travel companies are perky about international travel, but are they telling anyone the truth?
Amid shocking news about rising COVID-19 deaths and health systems collapsing across the world, travel companies are remaining perky. When will somebody tell us the truth about international travel?
Unfair dismissal claims and disputes expected to rise post-JobKeeper. Here’s what business owners need to do
With the three key pillars of business support — JobKeeper, JobSeeker and insolvent trading relief laws — coming to an end, it’s time for many businesses to make decisions about the future.
Unemployment could soon be higher than 7%. Here’s why
It’s not just the end of JobKeeper that will push up unemployment in April. Here are the other changes causing the rise.
Employee retention: Why you should care and how to do it right
The traditional drivers of employee retention have transformed. How can we utilise these retention drivers to motivate a weary workforce?
Ditch the buzzwords: Why searching for the ‘new normal’ is harming your business
By thoughtlessly using overused phrases and pandemic buzzwords at any opportunity, businesses run the risk of becoming a mere echo.
Melbourne SMEs to suffer the most in the post-JobKeeper era
There’s still a big gap left by JobKeeper in Victoria, after repeated lockdowns left Melbourne businesses economically vulnerable.
“Not even close”: Despite no international travel, the airline industry hasn’t collapsed
Globally, the main reason for the lack of large-scale airline bankruptcies has been government assistance.
Data shows women suffer from Zoom fatigue more intensely than men, so what’s to blame?
A new Stanford study reveals how the shift from in-person meetings to online ones has taken its toll more intensely among women.
Adam Schwab: Why an entrepreneur should have handled Australia’s vaccine rollout
Australia’s vaccine rollout resembled what happens when a big corporate tries to compete against a nimble startup. Despite superior resources, the startup inevitably wins.
After seven years of fizzy growth, Aussie effervescent vitamins brand Voost sells to Procter & Gamble
VitaminHaus, along with its consumer brand of Voost effervescent vitamins, has been acquired by consumer goods behemoth Procter & Gamble.
A plane crash or Australia’s vaccine rollout? Adam Schwab says there are plenty of similarities
"Somehow, one of the richest countries in the world and the home to CSL, one of the largest global biotechnology manufacturers, looks set to be slower than developing backwaters in vaccinating their population."